Clinical Trial

Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients

Name: Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients — clinical trial record (NCT07242482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Investigating the Clinical Value of Tumor Antigen-Specific T Cells and Immune Cell Balance in Peripheral Blood of Non-Small Cell Lung Cancer Patients for Prognostic Evaluation.

Trial Details

NCT Number	NCT07242482
Lead Sponsor	Zhao Jun
Conditions	Lung Cancer (Diagnosis), Biomarkers / Blood
Enrollment	200 participants
Start Date	2025-12-17
Primary Completion	2029-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-21